M05.079
Felty's syndrome, unspecified ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Felty's syndrome is a rare but serious complication often associated with long-standing rheumatoid arthritis. It is characterized by the triad of rheumatoid arthritis, an enlarged spleen (splenomegaly), and a decreased number of a type of white blood cell called neutrophils (neutropenia). This condition increases the risk of infections and other health issues. The specific code M05.079 refers to Felty's syndrome affecting the ankles and feet, although the syndrome can involve other parts of the body. Understanding this condition can help in recognizing its signs and seeking appropriate medical attention.
Causes & Symptoms
Clinical Causes: Chronic rheumatoid arthritis ongoing for many years Genetic factors that may predispose individuals to autoimmune conditions Immune system dysfunction leading to increased destruction of white blood cells and spleen enlargement Possible environmental factors that may trigger immune responses
Key Symptoms: Enlarged spleen causing discomfort or fullness in the abdomen Persistent or recurrent infections due to neutropenia Joint pain, swelling, and stiffness characteristic of rheumatoid arthritis Fatigue and weakness Fever and other signs of infection In some cases, redness or swelling in the ankles and feet, reflecting inflammation or associated conditions
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key steps include: - Blood tests to check for low neutrophil counts and rheumatoid factor levels - Imaging studies such as ultrasound or MRI to assess spleen size and joint involvement - Physical examination focusing on the joints, spleen, and signs of infection - Exclusion of other potential causes for neutropenia and splenomegaly A comprehensive assessment helps confirm the presence of Felty's syndrome and its extent.
Treatment Protocols: Management of Felty's syndrome typically entails addressing both the underlying rheumatoid arthritis and the complications related to neutropenia. Standard approaches include: - Medications to control rheumatoid arthritis, such as disease-modifying antirheumatic drugs (DMARDs) like methotrexate - Use of granulocyte colony-stimulating factor (G-CSF) to help boost neutrophil production - Antibiotics promptly used to treat infections due to increased infection risk - Splenectomy (surgical removal of the spleen) in severe cases when blood cell counts do not improve - Regular monitoring of blood counts and infection signs - Supportive care measures to manage symptoms and prevent complications It is essential to work closely with healthcare providers to determine an individualized treatment plan based on disease severity and response.
Clinical Advice & FAQs
Billing Guidance
Is M05.079 a billable ICD-10 code?
Yes, M05.079 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M05.079?
Clinical documentation must specify the nature of Felty's syndrome, unspecified ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference